Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

During the Trading Day
41.42 -9.12 / -18.05%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
41.50 +0.08 / +0.19%
 
Volume: 29.2K

Today’s Trading

Previous close50.54
Today’s open43.95
Day’s range40.04 - 44.00
Volume33,288,630
Average volume (3 months)7,688,551
Market cap$24.9B
Dividend yield--
Data as of 4:00pm ET, 02/11/2016

Growth & Valuation

Earnings growth (last year)+48.10%
Earnings growth (this year)+21.77%
Earnings growth (next 5 years)+7.80%
Revenue growth (last year)+11.45%
P/E ratio17.9
Price/Sales2.89
Price/Book5.82

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...-2.52-2.93%
PRGOPerrigo Company PLC-2.39-1.74%
VRTXVertex Pharmaceutica...-2.02-2.47%
ZTSZoetis Inc+0.03+0.08%
Data as of 4:05pm ET, 02/11/2016

Financials

Last reporting dateFebruary 11, 2016
EPS forecast (this quarter)$1.28
Annual revenue (last year)$7.8B
Annual profit (last year)$929.4M
Net profit margin11.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Potters Bar, Hertfordshire

Forecasts

Partner Offers